ALDH1A3 levels are also dysregulated at the protein level in glioma stem cells, where ubiquitin-specific protease 9X (USP9X) deubiquitinates ALDH1A3, leading to its increased stabilization and levels [82]. This evidence concerns the gene ALDH1A3 and central nervous system cancer.